NIR Fluorescence Molecular Imaging of ANXV-800CW in RVO Patients
NCT05133791
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Retinal Vein Occlusion
Interventions
DRUG:
Annexin A5
Sponsor
University Medical Center Groningen